Hormonal Therapies for Patients with Advanced Prostate Cancer
Prostate cancer (PCa) is the second most common cancer in men, comprising 15% of new cancer cases. While most cases are diagnosed at an early stage and can be managed conservatively or by local treatment alone, up to 30% of patients will receive androgen deprivation therapy (ADT). Indeed, high-risk...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2016-01-01
|
| Series: | European Medical Journal |
| Subjects: | |
| Online Access: | https://emj.emg-health.com/wp-content/uploads/sites/2/2018/01/Hormonal-Therapies-for-Patients-with-Advanced-Prostate-Cancer.pdf |